Security key
142152107
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)
CUSIP: 142152107
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 39,176
- Total 13F value
- $698,251
- Share change
- +35,998
- SEC-reported price per share
- $17.82
- Number of holders
- 7
- Value change
- +$641,808
- Number of buys
- 4
- Number of sells
- 3
- Shares outstanding
- 282,066,647
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
7
Top holders
7
CAI full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Caris Life Sciences, Inc. SEC filings
Caris Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 142152107
Recent filing periods:
Ownership snapshot
Top reported holders of CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
David D. Halbert
Disclosed value leader
David D. Halbert
Comparable rows
15/15
Latest evidence
29 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 44%
13D/G row: David D. Halbert
Showing 1-6 of 15 holder rows.
Quick read
David D. Halbert leads the comparable SEC ownership view at 44%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens David D. Halbert's linked filing trail.
Comparable ownership
Top 5
David D. Halbert
44%
FMR LLC
11%
J H Whitney VI L P
6.5%
TSSP Sub-Fund HoldCo LLC
5.1%
RIVERVIEW GROUP LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| David D. Halbert |
13D/G
3/4/5
Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner
|
44%
|
$3,311,265,907
124,906,296 shares
|
$0 | 30 Jun 2025 |
| FMR LLC |
13F
13D/G
Company
|
11%
from 13D/G
|
$550,446,260
30,785,585 shares
|
— | 31 Mar 2026 |
| J H Whitney VI L P |
13D/G
3/4/5
10%+ Owner
|
6.5%
|
$329,531,901
18,256,615 shares
|
-$36,100,000 | 31 Mar 2026 |
| TSSP Sub-Fund HoldCo LLC |
13D/G
3/4/5
Alan Waxman · Former 10% Owner
|
5.1%
|
$259,656,452
14,385,399 shares
|
-$90,250,000 | 31 Mar 2026 |
| RIVERVIEW GROUP LLC |
13D/G
Millennium Management LLC
|
1.3%
|
—
3,583,100 shares
|
$0 | 17 Jun 2025 |
| Peter M. Castleman |
3/4/5
Director
|
3.7%
|
$275,313,217
10,395,044 shares
|
— | 26 Feb 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
39,176
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
200
Q2 2026 holders
7
Holder diff
-193
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend